Login / Signup

The partial dopamine D2 receptor agonist aripiprazole is associated with weight gain in adolescent anorexia nervosa.

Guido K W FrankMegan E ShottJennifer O HagmanMarissa A SchielMarisa C DeGuzmanBrogan Rossi
Published in: The International journal of eating disorders (2017)
The use of dopamine receptor agonists may support treatment success in anorexia nervosa and should be further investigated.
Keyphrases
  • anorexia nervosa
  • weight gain
  • body mass index
  • birth weight
  • young adults
  • mental health
  • weight loss
  • atomic force microscopy
  • metabolic syndrome
  • replacement therapy
  • smoking cessation